For example, the NEFRONA study showed an increase in circulating ADAM17 in plasma samples from patients with CKD (without a previous history of CVD) with advanced CKD (stage 5D) compared to patients with moderate CKD (stage 3–5) [153]. The gene discussed is ADAM17; the disease is chronic kidney disease.